Novo Nordisk Stock Analysis | Buy This Pharmaceutical Giant?

Novo Nordisk is one of the largest pharmaceutical companies in the world. With its release of Ozempic/Wegovy, breakthrough weight loss and diabetes medicines, their surge in earnings has contributed to all of Denmark's GDP growth in the last 6 months! It has also generated a lot of hype and caused the share price to surge. In this episode I do a review of the company and assess its intrinsic fair value through a DCF analysis. Is NVO a good buy at the current price??

Financials from Q4 (December) 2023.

⬤ https://www.macrotrends.net/stocks/ch...

🎥Related Videos🎥
How to Find the Intrinsic Value of a Stock:    • How to Find the Intrinsic Value of a ...  
Google Stock Valuation with DCF:    • Google Stock Analysis and Valuation |...  

★☆★ Subscribe: ★☆★
https://t.ly/yJ1-S

Follow me on Twitter: @CailonCapital
►  / cariloncapital  

🟠Support Me on Patreon🟠
►patreon.com/CarilonCapitalResearch

Start trading on Interactive Brokers with my link and get free stocks!
►https://ibkr.com/referral/kurt526

Best luck investing and God bless!
#valueinvesting #stockmarket #discountedcashflow #NVO #novonordisk #stockanalysis